RecallGuardianCanada
Drugs· Type I· Updated August 19, 2024

JAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules

Critical priority
What you should do
  1. 1If you are taking this medication, speak with your pharmacist as soon as possible.
  2. 2Your pharmacist will check if your product is affected by the recall and provide a replacement if needed.
  3. 3Given the capsule format, it is not possible to know whether your capsule is overweight or underweight by looking at it.
  4. 4Continue taking your medication until you speak with your pharmacist, as mycophenolate is an important drug in preventing organ rejection in kidney, heart or liver transplant patients.
  5. 5Contact a health care professional immediately if you or someone you are caring for experience serious side effects.
The issue

Product safety

Affected product

JAMP-Mycophenolate 250mg

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada — Drugs and health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls